Sintilimab Provides 'Robust' Survival Benefit in Advanced NS

Adding sintilimab to chemotherapy improves overall survival in patients with advanced, nonsquamous non-small cell lung cancer.

Related Keywords

China , Guangzhou , Guangdong , Yunpeng Yang , European Lung Cancer Congress , Sun Yat Sen University Cancer Center , Lung Cancer Congress ,